Our new paper on YWHAG-neurodevelopmental disorders is out! 🧬
https://t.co/8xN4jE8Cwj
We uncovered molecular defects in 14-3-3γ variants & built a novel BRET assay for binding analysis—now a platform for drug discovery.
Huge thanks to the team @solis_gp et al! 🙌
@Cells_MDPI
The first-in-human study of #Zinc supplementation in #GNAO1 related encephalopathy is out @MedCellPress https://t.co/MhfQTHATg9
Congrats @yonikalarasati and @Thiel_Mo
Let's hope the clinical trial bring some good news in the near future 🙏
Happy to see our last paper @jclinicalinvest highlighted in @unige_en The more we look, the more surprises we found in @GNAO1 mutations. The end goal is to get some help for the patients 🙏
https://t.co/qMS2xU4KLm
GNAO1 encephalopathies, which cause epilepsy and intellectual disability from birth, are linked to mutations in the GNAO1 gene. Professor Katanaev's team has discovered that certain mutations grant a new function to the protein encoded by the GNAO1 gene.
https://t.co/x5toTjJae5
Happy to see our last paper @jclinicalinvest highlighted in @UNIGEnews The more we look, the more surprises we found in @GNAO1 mutations. The end goal is to get some help for the patients 🙏
https://t.co/qMS2xU4KLm
Les encéphalopathies GNAO1, causant épilepsie et déficience intellectuelle 🧠 dès la naissance, sont liées à des mutations du gène GNAO1 🧬. L'équipe de Vladimir Katanaev, professeur à la Faculté de médecine, a découvert que certaines mutations confèrent une nouvelle fonction à la protéine codée par le gène GNAO1. Une avancée clé pour de futurs traitements.
Plus d’infos 👉 https://t.co/faDkAoIQSd
#GNAO1 #recherche #maladiesrares #médecine
Gracias @yonikalarasati y equipo por vuestro nuevo artículo #GNAO1 y por colaborar para su desarrollo con otros equipos de investigación.
Somos muy afortunados de contar con vuestro trabajo🙌🙏!!
👇👇📋👩🔬👇👇
Ayer y hoy estamos disfrutando esperanzados con la Conferencia #GNAO1 organizada por @GNAO1Bow en Boston.
Médicos e investigadores de todo el mundo con un único objetivo,entender nuestra enfermedad y conseguir tratamientos y terapias efectivos🤞🤞🤞.
https://t.co/DoNDE6z7X3
Our collaborative work with Spanish clinicians demonstrates a genotype-phenotype correlation in the Spanish cohort of patients.
Many thanks to @Gnao1Espana who funded our research.
Cheers to the GNAO1 team @solis_gp 🥳
@MDJ_Journal
Our last study describing the neomorphic nature of #GNAO1 mutations is finally out
https://t.co/P7lMRBfVZH
Congrats @arghavankz and thanks, your contribution was great and you are dearly missed in the lab!!!
#GPCR#RareDisease#EERR
⏰ Just one day to go until #RareDiseaseDay 2024!
#DidYouKnow there are 6000+ known rare diseases?
Visit https://t.co/NcPf3U6RNP for key statistics on rare conditions. 🦓
#ShareYourColours
🚨 IT'S RARE DISEASE DAY GLOBALLY! 🚨 Join us marking #RareDiseaseDay 2024! Spread awareness, share stories, and support those living with rare diseases. Together, we make a lasting impact! #ShareYourColours
#29F#RareDiseaseDay#DiaMundialEnfermedadesRaras
Nacimos con el documental q nos dio nombre
“Raras pero no invisibles”⤵️
https://t.co/XLjmOJikEX
Y somos una ventana, abierta para q las #EERR sean visibles, compartir dolor y esperanza, reivindicar, aportar, apoyar.
Y… seguimos🤗
Aquí junto a @yonikalarasati caracterizamos dos curiosas #GNAO1 mutaciones que producen síntomas hipocinético típicos de parkinsonismo, expandiendo así el espectro fenotípico de la encefalopatía GNAO1. En colaboración con @Thiel_Mo
New story on #GNAO1 🤓https://t.co/QK2BtqeDcs
Glad to contribute to this story, led by @solis_gp and Prof. Katanaev!
We characterized two #GNAO1 variants with hypokinetic phenotypes, instead of the more common hyperkinetic movement disorders.
Aquí el preprint del primer caso clínico de un tratamiento con Zinc y que variantes de GNAO1 respend a Zinc.
Read this #preprint on @researchsquare: Zinc for #GNAO1 encephalopathy: preclinical profiling and a clinical case https://t.co/3VBgaktpmw
Aquí el preprint del primer caso clínico de un tratamiento con Zinc y que variantes de GNAO1 respend a Zinc.
Read this #preprint on @researchsquare: Zinc for #GNAO1 encephalopathy: preclinical profiling and a clinical case https://t.co/3VBgaktpmw